Top Markets
Coin of the day
BioNxt Solutions Inc. BioNxt Solutions Inc.

BioNxt Solutions Inc.

BNXT
Rankning i aktier #27435
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017,... Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
Aktiekurs
$0.25320823
Senast synkroniserad: 2026-08-19
Marknadsvärde
$32.92M
Förändring (1 dag)
2.99%
Förändring (1 år)
-65.56%
Land
CA
Handel BioNxt Solutions Inc. (BNXT)

Kategori

Historik för aktiesplit för BioNxt Solutions Inc. (BNXT)
Aktien BioNxt Solutions Inc. (symbol: BNXT) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 20, 2026.
En BNXT-aktie köpt före Aug 20, 2026 motsvarar nu 0 BNXT-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter